ATE104299T1 - Pyrrolophthalazine. - Google Patents

Pyrrolophthalazine.

Info

Publication number
ATE104299T1
ATE104299T1 AT88311468T AT88311468T ATE104299T1 AT E104299 T1 ATE104299 T1 AT E104299T1 AT 88311468 T AT88311468 T AT 88311468T AT 88311468 T AT88311468 T AT 88311468T AT E104299 T1 ATE104299 T1 AT E104299T1
Authority
AT
Austria
Prior art keywords
aryl
optionally substituted
substituted alkyl
heteroaryl
alkynyl
Prior art date
Application number
AT88311468T
Other languages
English (en)
Inventor
Michael John Ashton
Andrew William Bridge
Donald Ian Dron
Garry Fenton
David John Lythgoe
Christopher Gregory Newton
David Riddell
Christopher Smith
Keith Alfred James Stuttle
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Application granted granted Critical
Publication of ATE104299T1 publication Critical patent/ATE104299T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT88311468T 1987-12-03 1988-12-02 Pyrrolophthalazine. ATE104299T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878728314A GB8728314D0 (en) 1987-12-03 1987-12-03 New compositions of matter
EP88311468A EP0319330B1 (de) 1987-12-03 1988-12-02 Pyrrolophthalazine

Publications (1)

Publication Number Publication Date
ATE104299T1 true ATE104299T1 (de) 1994-04-15

Family

ID=10627948

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88311468T ATE104299T1 (de) 1987-12-03 1988-12-02 Pyrrolophthalazine.

Country Status (6)

Country Link
US (1) US4960775A (de)
EP (1) EP0319330B1 (de)
JP (1) JPH01186888A (de)
AT (1) ATE104299T1 (de)
DE (1) DE3889083D1 (de)
GB (1) GB8728314D0 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018903A1 (en) * 1990-05-25 1991-12-12 Fujisawa Pharmaceutical Co., Ltd. Pyrrolopyridazine compounds
GB0228894D0 (en) * 2002-12-11 2003-01-15 Avecia Ltd Process
TWI695839B (zh) * 2017-11-17 2020-06-11 中央研究院 雙(羥甲基)吡咯并酞嗪混成物、其之製備方法與用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH544763A (de) * 1970-03-26 1974-01-15 Siegfried Ag Verfahren zur Herstellung von Spiro-Additionsprodukten aus N-haltigen Heterocyclen und Maleinimiden
CH644459A5 (de) * 1978-09-29 1984-07-31 Ciba Geigy Ag Verfahren zur herstellung farbphotographischer bilder nach dem silberfarbbleichverfahren.
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
CA1317945C (en) * 1985-12-13 1993-05-18 Ulf Fischer Tricyclic pyridazopyridone derivatives
NO881411L (no) * 1987-04-14 1988-10-17 Bayer Ag Substituerte pyrroler.
EP0294599A3 (de) * 1987-06-12 1990-05-09 F. Hoffmann-La Roche Ag Tricyclische Pyridonderivate

Also Published As

Publication number Publication date
EP0319330A2 (de) 1989-06-07
GB8728314D0 (en) 1988-01-06
US4960775A (en) 1990-10-02
EP0319330B1 (de) 1994-04-13
JPH01186888A (ja) 1989-07-26
EP0319330A3 (de) 1991-01-16
DE3889083D1 (de) 1994-05-19

Similar Documents

Publication Publication Date Title
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
IL75115A (en) 3-oxadiazolyl-beta-carboline derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
EP0326386A3 (de) Isochinolinone
HUT59693A (en) Process for producing morpholinyl derivatives of doxorubicin and pharmaceutical compositions containing them
DE3068379D1 (en) Indolobenzoxazines, processes for preparing and pharmaceutical compositions containing the same
AU7987587A (en) Quinoline base compound, process for the preparation thereof and anticancer agent containing the same as pharmacologically efficacious component
DE3889083D1 (de) Pyrrolophthalazine.
AU634669B2 (en) Halogenoalkyl azolyl derivatives
ATE106079T1 (de) Pyrroloisochinoline.
HUT47535A (en) Process for producing ethanonoxime derivatives and pharmaceuticals comprising such active ingredient
EP0250814A3 (en) Prophylactic and curing composition containing a 8-chlorobenzothiazepine compound and its use
IL94935A0 (en) Novel acrylic acid salts,a process for their preparation and pharmaceutical compositions containing them
PT73948B (en) Process for the preparation of biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
SE9002445L (sv) Nytt cyklobutanderivat och foerfarande foer framstaellning av detsamma
SE7503729L (de)
AU8292787A (en) Fluorine-containing macrolide compounds and their use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties